USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Emerging Therapeutic Segments in the European Biopharmaceutical Markets
Emerging Therapeutic Segments in the European Biopharmaceutical Markets
RELEASE DATE
14-Aug-2009
14-Aug-2009
REGION
Europe
Europe
Research Code: M405-01-00-00-00
SKU: HC01801-EU-MR_06651
$4,950.00
In stock
SKU
HC01801-EU-MR_06651
Description
The research services provides an analysis of the European markets for emerging therapeutic areas such as antisense therapy, gene therapy and cell therapy. The research services segments the market based on the drug classes. The research analyses the challenges faced by the biopharmaceutical industry and the potential uses for the emerging therapeutic areas. The research also provides market sizes for the total biopharmaceutical markets and the market for emerging therapeutic areas.
Table of Contents
Introduction
- Summary
Market Introduction
- Introduction
- Market Engineering Measurements
- Main Classes of Biopharmaceuticals
- Recent Product Approvals in Europe
- Competitive Structure
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Pipeline Analysis
- Antisense Therapies
- Gene Therapies
- Cell Therapies
Total Market Forecasts
Segment Analysis
Popular Topics
The research services provides an analysis of the European markets for emerging therapeutic areas such as antisense therapy, gene therapy and cell therapy. The research services segments the market based on the drug classes. The research analyses the challenges faced by the biopharmaceutical industry and the potential uses for the emerging therapeutic areas. The research also provides market sizes for the total biopharmaceutical markets and the market for emerging therapeutic areas.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | M405-01-00-00-00 |
| Is Prebook | No |